Hot Pursuit     02-Jan-24
Zydus Lifesciences Ltd gains for third straight session
Zydus Lifesciences Ltd is quoting at Rs 711, up 1.69% on the day as on 12:49 IST on the NSE. The stock is up 67.43% in last one year as compared to a 18.64% jump in NIFTY and a 36.1% jump in the Nifty Pharma index.

Zydus Lifesciences Ltd is up for a third straight session today. The stock is quoting at Rs 711, up 1.69% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is down around 0.51% on the day, quoting at 21632. The Sensex is at 71811.63, down 0.64%. Zydus Lifesciences Ltd has gained around 12.25% in last one month.

Meanwhile, Nifty Pharma index of which Zydus Lifesciences Ltd is a constituent, has gained around 6.02% in last one month and is currently quoting at 16858.75, up 2.06% on the day. The volume in the stock stood at 17.57 lakh shares today, compared to the daily average of 18.49 lakh shares in last one month.

The benchmark January futures contract for the stock is quoting at Rs 715, up 1.44% on the day. Zydus Lifesciences Ltd is up 67.43% in last one year as compared to a 18.64% jump in NIFTY and a 36.1% jump in the Nifty Pharma index.

The PE of the stock is 28.35 based on TTM earnings ending September 23.

Previous News
  Zydus Lifesciences consolidated net profit rises 298.62% in the March 2024 quarter
 ( Results - Announcements 17-May-24   16:25 )
  Zydus completes Phase II clinical study of NLRP3 inhibitor ‘Usnoflast (ZYIL1)'
 ( Corporate News - 24-May-24   16:02 )
  Zydus Lifesciences Ltd slips for fifth straight session
 ( Hot Pursuit - 30-May-24   13:35 )
  Zydus Lifesciences Ltd gains for third straight session
 ( Hot Pursuit - 11-Sep-24   13:06 )
  Zydus Lifesciences consolidated net profit rises 26.76% in the December 2023 quarter
 ( Results - Announcements 09-Feb-24   14:29 )
  Zydus Life gets USFDA nod for Zituvimet XR tablets
 ( Hot Pursuit - 19-Jul-24   11:53 )
  Zydus Lifesciences to hold AGM
 ( Corporate News - 17-May-24   17:45 )
  Board of Zydus Lifesciences recommends Final Dividend
 ( Corporate News - 17-May-24   16:18 )
  USFDA conducts inspection of Zydus' API site at Changodar, Ahmedabad
 ( Corporate News - 22-Dec-23   19:54 )
  Zydus Life Q3 PAT climbs 27% YoY to Rs 790 cr; board OKs Rs 600 cr share buyback
 ( Hot Pursuit - 09-Feb-24   14:22 )
  Zydus receives USFDA approval for Zituvimet™ XR tablets
 ( Corporate News - 19-Jul-24   13:58 )
Other Stories
  Avantel Q2 PAT jumps 42% YoY to Rs 23 cr
  05-Oct-24   17:03
  Equitas SFB total deposits jump 29% YoY in Q2 FY25
  05-Oct-24   16:28
  Ujjivan SFB total deposits rises 17% in Q2 FY25
  05-Oct-24   15:34
  L&T Finance retail disbursements jump 12% YoY in Q2 FY25
  05-Oct-24   14:31
  Bandhan Bank records over 21% YoY jump in loan book during Q2 FY25; deposits at Rs 1.42 lakh crore
  05-Oct-24   13:32
  Lupin's Pune-based biotech facility gets 5 observations from US FDA
  05-Oct-24   13:20
  Macrotech Developers pre-sales jumps 21% YoY in Q2 FY25
  05-Oct-24   09:04
  UCO Bank’s total advances jump 19% YoY in Q2 FY25
  04-Oct-24   15:15
  Vakrangee Ltd leads losers in 'A' group
  04-Oct-24   15:00
  Kamdhenu Ventures Ltd leads losers in 'B' group
  04-Oct-24   14:45
Back Top